Overlap syndrome of polymyositis and progressive systemic sclerosis associated with interferon therapy for chronic hepatitis C

T. Otsuka, N. Sakamoto, Y. Tanaka, Kunihiro Yamaoka, H. Nakashima, S. Yoshizawa, T. Horiuchi, Y. Niho

Research output: Contribution to journalArticle

Abstract

Interferon (IFN)-α therapy may induce, reveal, or exacerbate various autoimmune-related disorders. We describe a 48-year-old female patient who developed muscle weakness during IFN-α therapy given for hepatitis C virus-associated chronic active hepatitis. This symptom diminished slightly after discontinuation of the therapy, but she then began to complain of Raynaud's phenomenon, swelling of bilateral dorsal hands and dysphagia. Accompanied by an elevation of serum antinuclear antibody, the subsequent development of polymyositis (PM) and progressive systemic sclerosis was considered to have been induced by the IFN-α.

Original languageEnglish
Pages (from-to)259-265
Number of pages7
JournalJapanese Journal of Rheumatology
Volume9
Issue number3
Publication statusPublished - 1999
Externally publishedYes

Fingerprint

Diffuse Scleroderma
Polymyositis
Chronic Hepatitis C
Interferons
Raynaud Disease
Antinuclear Antibodies
Muscle Weakness
Chronic Hepatitis
Deglutition Disorders
Hepacivirus
Therapeutics
Hand
Serum

Keywords

  • Antinuclear antibody
  • Interferon-α
  • Polymyositis
  • Progressive systemic sclerosis

ASJC Scopus subject areas

  • Rheumatology

Cite this

Otsuka, T., Sakamoto, N., Tanaka, Y., Yamaoka, K., Nakashima, H., Yoshizawa, S., ... Niho, Y. (1999). Overlap syndrome of polymyositis and progressive systemic sclerosis associated with interferon therapy for chronic hepatitis C. Japanese Journal of Rheumatology, 9(3), 259-265.

Overlap syndrome of polymyositis and progressive systemic sclerosis associated with interferon therapy for chronic hepatitis C. / Otsuka, T.; Sakamoto, N.; Tanaka, Y.; Yamaoka, Kunihiro; Nakashima, H.; Yoshizawa, S.; Horiuchi, T.; Niho, Y.

In: Japanese Journal of Rheumatology, Vol. 9, No. 3, 1999, p. 259-265.

Research output: Contribution to journalArticle

Otsuka, T, Sakamoto, N, Tanaka, Y, Yamaoka, K, Nakashima, H, Yoshizawa, S, Horiuchi, T & Niho, Y 1999, 'Overlap syndrome of polymyositis and progressive systemic sclerosis associated with interferon therapy for chronic hepatitis C', Japanese Journal of Rheumatology, vol. 9, no. 3, pp. 259-265.
Otsuka, T. ; Sakamoto, N. ; Tanaka, Y. ; Yamaoka, Kunihiro ; Nakashima, H. ; Yoshizawa, S. ; Horiuchi, T. ; Niho, Y. / Overlap syndrome of polymyositis and progressive systemic sclerosis associated with interferon therapy for chronic hepatitis C. In: Japanese Journal of Rheumatology. 1999 ; Vol. 9, No. 3. pp. 259-265.
@article{dd3527425a974bdeb5842aefd3fa790e,
title = "Overlap syndrome of polymyositis and progressive systemic sclerosis associated with interferon therapy for chronic hepatitis C",
abstract = "Interferon (IFN)-α therapy may induce, reveal, or exacerbate various autoimmune-related disorders. We describe a 48-year-old female patient who developed muscle weakness during IFN-α therapy given for hepatitis C virus-associated chronic active hepatitis. This symptom diminished slightly after discontinuation of the therapy, but she then began to complain of Raynaud's phenomenon, swelling of bilateral dorsal hands and dysphagia. Accompanied by an elevation of serum antinuclear antibody, the subsequent development of polymyositis (PM) and progressive systemic sclerosis was considered to have been induced by the IFN-α.",
keywords = "Antinuclear antibody, Interferon-α, Polymyositis, Progressive systemic sclerosis",
author = "T. Otsuka and N. Sakamoto and Y. Tanaka and Kunihiro Yamaoka and H. Nakashima and S. Yoshizawa and T. Horiuchi and Y. Niho",
year = "1999",
language = "English",
volume = "9",
pages = "259--265",
journal = "Modern Rheumatology",
issn = "1439-7595",
publisher = "Springer Japan",
number = "3",

}

TY - JOUR

T1 - Overlap syndrome of polymyositis and progressive systemic sclerosis associated with interferon therapy for chronic hepatitis C

AU - Otsuka, T.

AU - Sakamoto, N.

AU - Tanaka, Y.

AU - Yamaoka, Kunihiro

AU - Nakashima, H.

AU - Yoshizawa, S.

AU - Horiuchi, T.

AU - Niho, Y.

PY - 1999

Y1 - 1999

N2 - Interferon (IFN)-α therapy may induce, reveal, or exacerbate various autoimmune-related disorders. We describe a 48-year-old female patient who developed muscle weakness during IFN-α therapy given for hepatitis C virus-associated chronic active hepatitis. This symptom diminished slightly after discontinuation of the therapy, but she then began to complain of Raynaud's phenomenon, swelling of bilateral dorsal hands and dysphagia. Accompanied by an elevation of serum antinuclear antibody, the subsequent development of polymyositis (PM) and progressive systemic sclerosis was considered to have been induced by the IFN-α.

AB - Interferon (IFN)-α therapy may induce, reveal, or exacerbate various autoimmune-related disorders. We describe a 48-year-old female patient who developed muscle weakness during IFN-α therapy given for hepatitis C virus-associated chronic active hepatitis. This symptom diminished slightly after discontinuation of the therapy, but she then began to complain of Raynaud's phenomenon, swelling of bilateral dorsal hands and dysphagia. Accompanied by an elevation of serum antinuclear antibody, the subsequent development of polymyositis (PM) and progressive systemic sclerosis was considered to have been induced by the IFN-α.

KW - Antinuclear antibody

KW - Interferon-α

KW - Polymyositis

KW - Progressive systemic sclerosis

UR - http://www.scopus.com/inward/record.url?scp=0032830271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032830271&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0032830271

VL - 9

SP - 259

EP - 265

JO - Modern Rheumatology

JF - Modern Rheumatology

SN - 1439-7595

IS - 3

ER -